Active Phytochemicals of Indian Spices Target Leading Proteins Involved in Breast Cancer: An in Silico Study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Indian spices are well known for their numerous health benefits, flavour, taste, and colour. Recent Advancements in chemical technology have led to better extraction and identification of bioactive molecules (phytochemicals) from spices. The therapeutic effects of spices against diabetes, cardiac problems, and various cancers has been well established. The present in silico study aims to investigate the binding affinity of 29 phytochemicals from 11 Indian spices with two prominent proteins, BCL3 and CXCL10 involved in invasiveness and bone metastasis of breast cancer. The three-dimensional structures of 29 phytochemicals were extracted from PubChem database. Protein Data Bank was used to retrieve the 3D structures of BCL3 and CXCL10 proteins. The drug-likeness and other properties of compounds were analysed by ADME and Lipinski rule of five (RO5). All computational simulations were carried out using Autodock 4.0 on Windows platform. The proteins were set to be rigid and compounds were kept free to rotate. In-silico study demonstrated a strong complex formation (positive binding constants and negative binding energy ΔG) between all phytochemicals and target proteins. However, piperine and sesamolin demonstrated high binding constants with BCL3 (50.681 × 103 mol-1, 137.76 × 103 mol-1) and CXCL10 (98.71 × 103 mol-1, 861.7 × 103 mol-1), respectively. The potential of these two phytochemicals as a drug candidate was highlighted by their binding energy of -6.5 kcal mol−1, -7.1 kcal mol−1 with BCL3 and -6.9 kcal mol−1, -8.2 kcal mol−1 with CXCL10, respectively coupled with their favourable drug likeliness and pharmacokinetics properties. These findings underscore the potential of piperine and sesamolin as drug candidates for inhibiting invasiveness and regulating breast cancer metastasis. However, further validation through in vitro and in vivo studies is necessary to confirm the in silico results and evaluate their clinical potential.
Abstract
Indian spices are well known for their numerous health benefits, flavour, taste, and colour. Recent Advancements in chemical technology have led to better extraction and identification of bioactive molecules (phytochemicals) from spices. The therapeutic effects of spices against diabetes, cardiac problems, and various cancers has been well established. The present in silico study aims to investigate the binding affinity of 29 phytochemicals from 11 Indian spices with two prominent proteins, BCL3 and CXCL10 involved in invasiveness and bone metastasis of breast cancer. The three-dimensional structures of 29 phytochemicals were extracted from PubChem database. Protein Data Bank was used to retrieve the 3D structures of BCL3 and CXCL10 proteins. The drug-likeness and other properties of compounds were analysed by ADME and Lipinski rule of five (RO5). All computational simulations were carried out using Autodock 4.0 on Windows platform. The proteins were set to be rigid and compounds were kept free to rotate. In-silico study demonstrated a strong complex formation (positive binding constants and negative binding energy ΔG) between all phytochemicals and target proteins. However, piperine and sesamolin demonstrated high binding constants with BCL3 (50.681 × 103 mol-1, 137.76 × 103 mol-1) and CXCL10 (98.71 × 103 mol-1, 861.7 × 103 mol-1), respectively. The potential of these two phytochemicals as a drug candidate was highlighted by their binding energy of -6.5 kcal mol−1, -7.1 kcal mol−1 with BCL3 and -6.9 kcal mol−1, -8.2 kcal mol−1 with CXCL10, respectively coupled with their favourable drug likeliness and pharmacokinetics properties. These findings underscore the potential of piperine and sesamolin as drug candidates for inhibiting invasiveness and regulating breast cancer metastasis. However, further validation through in vitro and in vivo studies is necessary to confirm the in silico results and evaluate their clinical potential.
참고문헌 (57)
- Łukasiewicz, S., , Cancers, 13, pp.4287~ (2021)
- Chavda, V. P., , Cancers, 15, pp.1023~ (2023)
- Harbeck, N., , Nat. Rev. Dis. Primer, 5, pp.66~ (2019)
- Kuchenbaecker, K. B., , Jama, 317, pp.2402~ (2017)
- Pan, Y., , Ann. Transl. Med, 9, pp.1340~ (2021)
- Macedo, F., , Oncol. Rev, 11, pp.321~ (2017)
- Singh, Y., , J. Integr. Bioinforma, 19, pp.20210041~ (2022)
- Kashatus, D., , Genes Dev, 20, pp.225~ (2006)
- Rocha, S., , Mol. Cell. Biol, 23, pp.4713~ (2003)
- Czapiewski, P., , Virchows Arch. Int. J. Pathol, 480, pp.529~ (2022)
- Turnham, D. J., , Biomedicines, 12, pp.143~ (2024)
- Zhang, Z., , Int. J. Biol. Sci, 20, pp.1356~ (2024)
- Seaton, G., , Mol. Cancer, 23, pp.7~ (2024)
- Yue, M., , Biomed Pharmacother Biomedecine Pharmacother, 170, pp.116040~ (2024)
- Choudhari, A. S., , Front Pharmacol, 10, pp.1614~ (2019)
- Zhou, Y., , Nutrients, 8, pp.156~ (2016)
- Zheng, J., , Nutrients, 8, pp.495~ (2016)
- Bensimon, J., , Mol. Carcinog, 55, pp.245~ (2016)
- Nemzer, B., (2023), Intech Open
- Lin, Y., , Cell. Mol. Biol. Lett, 29, pp.63~ (2024)
- Nayana, P., , J. Biomol. Struct. Dyn, 26, pp.1~ (2024)
- Michel, F., , EMBO J, 20, pp.6180~ (2001)
- O’Boyle, N. M., , J. Cheminformatics, 3, pp.33~ (2011)
- Soukupová, J., , Mol. Cancer. Ther, 20, pp.775~ (2021)
- Pettersen, E. F., , J. Comput. Chem, 25, pp.1605~ (2004)
- Ahuja, A., , Int. J. Biol. Macromol, 179, pp.586~ (2021)
- Guex, N., , Electrophoresis, 18, pp.2714~ (1997)
- Hay, M., , Nat. Biotechnol, 32, pp.40~ (2014)
- Himmelstein, D. S., , Pharmacol Ther, 136, pp.8~ (2012)
- Yu, W., , Methods Mol. Biol. Clifton. NJ, 1520, pp.85~ (2017)
- Nazir, N., , Ethnopharmacol, 210, pp.198~ (2018)
- Baloghová, J., , Mol. Basel. Switz, 28, pp.6251~ (2023)
- Kostelecka, K., , Cancers, 16, pp.1611~ (2024)
- da Silva, M. M., , Mol. Basel. Switz, 20, pp.5360~ (2015)
- Liu, M., , Oncol Lett, 2, pp.583~ (2011)
- Wakefield, A., , Cancer Res, 73, pp.745~ (2013)
- Pratt, M. A. C., , Mol. Cell. Biol, 23, pp.6887~ (2003)
- Huo, J., , Acta Biochim Biophys Sin, 50, pp.1141~ (2018)
- Chen, X., , Cell. Death. Dis, 7, pp.e2508~ (2016)
- Choi, J., , Int. J. Mol. Sci, 19, pp.2607~ (2018)
- Perrott, K. M., , GeroScience, 39, pp.161~ (2017)
- Rather, R. A., , Front. Cell. Dev. Biol, 6, pp.10~ (2018)
- Zadorozhna, M., , Mol. Biol. Rep, 46, pp.5617~ (2019)
- Greenshields, A. L., , Cancer Lett, 357, pp.129~ (2015)
- Arunodaya, H., , Ind. J. Nat. Products Resources, 13, pp.206~ (2022)
- Köhrmann, A., , BMC Cancer, 16, pp.188~ (2009)
- Arun, A., , Cell. Prolif, 51, pp.e12501~ (2018)
- Erden, Y., , Nutr Cancer, 73, pp.662~ (2021)
- Srisongkram, T., , Int. J. Mol. Sci, 23, pp.8446~ (2022)
- Wu, D., , Cell. Mol. Biol, 65, pp.96~ (2019)
- He, S. M., , Curr. Pharm. Des, 17, pp.357~ (2011)
- Roos, C., , Mol. Pharm, 14, pp.4252~ (2017)
- Seelig, A., , Front Oncol, 10, pp.576559~ (2020)
- Chan, L. M. S., , Eur. J. Pharm. Sci, 21, pp.25~ (2004)
- Yu, X. Q., , Curr. Drug. Metab, 8, pp.787~ (2007)
- Chatterjee, P., , Drug. Metab. Dispos. Biol. Fate. Chem, 31, pp.1391~ (2003)
- Obuotor, T., , Res Sq, 2 (2021)